Print this article

Xellia Pharmaceuticals

e-version image

Click HERE to download the PDF version


Xellia Pharmaceuticals is a world leader in the development, manufacture and supply of fermented anti-infectives sold as active pharmaceutical ingredients (APIs) and finished dosage forms (FDFs) to the global pharmaceutical market. The company’s product range covers anti-infectives, treating certain serious and life-threatening bacterial and fungal infections; Xellia being the world leading supplier of vancomycin and colistimethate sodium (